Gordie Howe's improved condition attributed to stem cell treatments in Mexico

Gordie Howe's family says the NHL legend's improved health is due to an unexpected source.

In a statement released Friday, Howe's family said Mr. Hockey was recently subject to a stem cell clinical trial at Novastem, a licensed distributor of Stemedica Cell Technologies based in Mexico.

The company's CEO, Dr. Maynard Howe, and vice president, Dave McGuigan, contacted the Howe family in November after hearing of Gordie's deteriorating condition.

Howe had a two-day, non surgical procedure done on Dec. 8. Here are more details, according to the release:

The treatment included neural stem cells injected into the spinal canal on Day 1 and mesenchymal stem cells by intravenous infusion on Day 2. His response was truly miraculous. At the end of Day 1 he was walking with minimal effort for the first time since his stroke. By Day 2 he was conversing comfortably with family and staff at the clinic.

On the third day, he walked to his seat on the plane under his own power. By Day 5 he was walking unaided and taking part in helping out with daily household chores. When tested, his ability to name items has gone from less than 25% before the procedure to 85% today. His physical therapists have been astonished. Although his short term memory, strength, endurance and coordination have plenty of room for improvement, we are hopeful that he will continue to improve in the months to come.

Howe appeared to be in dire straits earlier this month, but reports of his improved condition coincide with the timeline outlined by Novastem.

He remains on track to make his final public appearance with Wayne Gretzky in February.

- with h/t to The Hockey News